Encompass Health Corporation Share-based Payment Arrangement, Expense
Encompass Health Corporation (EHC) reported Share-based Payment Arrangement, Expense of $13.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-07
- Encompass Health Corporation share-based payment arrangement, expense for the quarter ending 2026-06-30 was $13.80M, a 3.50% decline year-over-year.
- Encompass Health Corporation share-based payment arrangement, expense for the quarter ending 2026-03-31 was $11.50M, a 21.05% increase year-over-year.
- Encompass Health Corporation share-based payment arrangement, expense for the quarter ending 2025-12-31 was $18.40M, a 47.20% increase year-over-year.
- Encompass Health Corporation share-based payment arrangement, expense for the quarter ending 2025-09-30 was $14.30M, a 10.85% increase year-over-year.
- Encompass Health Corporation share-based payment arrangement, expense for fiscal 2025 was $56.50M, a 16.98% increase from fiscal 2024.
- Encompass Health Corporation share-based payment arrangement, expense for fiscal 2024 was $48.30M, a 4.55% decline from fiscal 2023.
- Encompass Health Corporation share-based payment arrangement, expense for fiscal 2023 was $50.60M, a 73.29% increase from fiscal 2022.
- Encompass Health Corporation share-based payment arrangement, expense for fiscal 2022 was $29.20M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.80M 10-Q · filed 2026-08-07 | $25.30M 10-Q · filed 2026-08-07 | $43.70M derived: sum of 3 quarters · filed 2026-08-07 | $58.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $11.50M 10-Q · filed 2026-05-01 | $29.90M derived: sum of 2 quarters · filed 2026-05-01 | $44.20M derived: sum of 3 quarters · filed 2026-05-01 | $58.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $18.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.70M derived: sum of 2 quarters · filed 2026-02-26 | $47.00M derived: sum of 3 quarters · filed 2026-08-07 | $56.50M 10-K · filed 2026-02-26 |
| 2025-09-30 | $14.30M 10-Q · filed 2025-10-31 | $28.60M derived: sum of 2 quarters · filed 2026-08-07 | $38.10M 10-Q · filed 2025-10-31 | $50.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $14.30M 10-Q · filed 2026-08-07 | $23.80M 10-Q · filed 2026-08-07 | $36.30M derived: sum of 3 quarters · filed 2026-08-07 | $49.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $9.50M 10-Q · filed 2026-05-01 | $22.00M derived: sum of 2 quarters · filed 2026-05-01 | $34.90M derived: sum of 3 quarters · filed 2026-05-01 | $48.50M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $12.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.40M derived: sum of 2 quarters · filed 2026-02-26 | $39.00M derived: sum of 3 quarters · filed 2026-02-26 | $48.30M 10-K · filed 2026-02-26 |
| 2024-09-30 | $12.90M 10-Q · filed 2025-10-31 | $26.50M derived: sum of 2 quarters · filed 2025-10-31 | $35.80M 10-Q · filed 2025-10-31 | |
| 2024-06-30 | $13.60M 10-Q · filed 2025-08-06 | $22.90M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $9.30M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $50.60M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $29.20M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |